FindMyRecallSubscribe
Class I: serious health riskTerminated

Endo Pharmaceuticals Clonazepam Orally Disintegrating Tablets Recall

Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0

Endo Pharmaceuticals, Inc. · Malvern, PA

Risk level
Class I
Reported by FDA
Aug 7, 2024
Recall ID
D-0622-2024
Check your lot numberHow we source this data

Summary

Endo Pharmaceuticals recalled Clonazepam Orally Disintegrating Tablets starting Jul 10, 2024. The FDA classified it as Class I (serious health risk) and published enforcement report D-0622-2024 on Aug 7, 2024. Reason: Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg. Status: Terminated.

Why it was recalled

Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.

Product description

Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC# 49884-306-02.

Lot numbers, UPCs & expiration codes

Lot 550147301, Exp. 08/31/2026

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0622-2024
Classification
Class I
Status
Terminated
Recall initiated
Jul 10, 2024
FDA report date
Aug 7, 2024
Quantity
8,139 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Endo Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0622-2024, exactly as published.

Show all FDA fields
City
Malvern
State
PA
Status
Terminated
Country
United States
Event ID
94945
Address
1400 Atwater Dr
Code information
Lot 550147301, Exp. 08/31/2026
Postal code
19355-8701
Report date
Aug 7, 2024
Product type
Drugs
Recall number
D-0622-2024
Classification
Class I
Recalling firm
Endo Pharmaceuticals, Inc.
Product quantity
8,139 cartons
Termination date
Sep 16, 2025
Reason for recall
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC# 49884-306-02.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Jul 10, 2024
Initial firm notification
Letter
Center classification date
Jul 30, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0622-2024, published Aug 7, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls